Control group n (%) or mean (SD) | Pandemic group n (%) or mean (SD) | p value | Total | |
---|---|---|---|---|
Total (n) | 10 (50.0) | 10 (50.0) | 20 (100.0) | |
Sex | ||||
Male | 8 (80.0) | 9 (90.0) | 1.000 | 17 (85.0) |
Female | 2 (20.0) | 1 (10.0) | 3 (15.0) | |
Age; years | 69.9 (9.4) | 67.3 (7.3) | 0.684 | 68.6 (8.3) |
Cholecystitis | 10 (100.0) | 10 (100.0) | 20 (100.0) | |
Gangrenous cholecystitis | 4 (40.0) | 3 (30.0) | 1.000 | 7 (35.0) |
Biliary pancreatitis | 1 (10.0) | 1 (10.0) | 1.000 | 2 (10.0) |
Early cholecystectomy | 8 (80.0) | 6 (60.0) | 0.628 | 14 (70.0) |
Operation time; min | 138.9 (54.5) | 152.2 (64.4) | 0.912 | 145.6 (58.5) |
IBL; ml | 333.3 (510.5) | 235.0 (122.6) | 0.356 | 281.6 (354.8) |
LOS; days | 11.5 (9.2) | 7.9 (2.5) | 0.739 | 9.7 (6.8) |
Overall morbidity | 2 (20.0) | 3 (30.0) | 1.000 | 5 (25.0) |
30-day mortality | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
Postoperative complications | ||||
Wound infection (CD 1) | 1 (10.0) | 1 (10.0) | 0.547 | 2 (10.0) |
Wound hematoma (CD 1) | 0 (0.0) | 1 (10.0) | 1 (5.0) | |
Postoperative pneumonia (CD 2) | 0 (0.0) | 1 (10.0) | 1 (5.0) | |
Iatrogenic bile duct injury (CD IIIb) | 1 (10.0) | 0 (0.0) | 1 (5.0) | |
Total | 2 (20.0) | 3 (30.0) | 5 (25.0) | |
Reason for conversion | ||||
Massive inflammatory adhesions | 4 (40.0) | 6 (60.0) | 0.315 | 10 (50.0) |
Dissection difficulties | 3 (30.0) | 4 (40.0) | 7 (35.0) | |
Bleeding | 2 (20.0) | 0 (0.0) | 2 (10.0) | |
Ventilation difficulties | 1 (10.0) | 0 (0.0) | 1 (5.0) | |
Total | 10 (100.0) | 10 (100.0) | 20 (100.0) |